SiRNA interfering STAT3 enhances DDP sensitivity in cervical cancer cells

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• Signal transducer and activator of transcription 3 (STAT3) is a key regulator in the JAK-STAT pathway, influencing cell proliferation and apoptosis.
• STAT3 dysregulation is implicated in tumor development, progression, and therapeutic resistance.
• Cervical cancer often exhibits resistance to chemotherapy, necessitating investigation into underlying molecular mechanisms.

Purpose of the Study:

• To investigate the role of STAT3 in cisplatin (DDP) resistance in cervical cancer cells.
• To determine the correlation between STAT3 expression levels and chemotherapy response in cervical cancer patients.

Main Methods:

• Comparison of STAT3 expression in cervical cancer tissues with varying responses to chemotherapy.
• Assessment of DDP's inhibitory effect on cervical cancer cells based on STAT3 expression levels.
• Western blot analysis of STAT3 and phosphorylated STAT3 (p-STAT3) in CaSki and CaSki/DDP cells.
• Flow cytometry for cell apoptosis analysis and EdU staining for cell proliferation assessment.
• RNA interference (siRNA) targeting STAT3 in CaSki/DDP cells to evaluate its functional impact.

Main Results:

• STAT3 overexpression was significantly higher in cervical cancer patients with poor chemotherapy response compared to those with good response.
• DDP exhibited a greater inhibitory effect and lower apoptosis rate in tumor cells with low STAT3 expression.
• Transfection with siRNA-STAT3 in CaSki/DDP cells led to reduced STAT3 and p-STAT3 expression, decreased cell proliferation, and enhanced apoptosis.

Conclusions:

• STAT3 overexpression is a significant factor associated with DDP resistance in cervical cancer.
• Targeting STAT3 by reducing its expression can enhance apoptosis and overcome DDP resistance in cervical cancer cells.